Epigenetic modifications of histone H4 in lung neuroendocrine tumors

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 5, 2011, Pages 389-394

  Li, Faqian ^a,b   Ye, Bo ^a   Hong, Longsheng ^b   Xu, Haodong ^a   Fishbein, Michael C ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

atypical carcinoid; epigenetic; histone; large cell neuroendocrine carcinoma; lung; neuroendocrine tumors; small cell lung carcinoma; typical carcinoid

Indexed keywords

BIOLOGICAL MARKER; HISTONE H4; KI 67 ANTIGEN; PROTEIN H4KA16; PROTEIN H4KM20; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CARCINOID; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE MODIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG NEUROENDOCRINE TUMORS; LUNG SMALL CELL CANCER; LUNG TUMOR; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SCORING SYSTEM;

ACETYLATION; CELL LINE, TUMOR; CELLS, CULTURED; EPIGENOMICS; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052756033     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3182108e2e     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin. 2008;58:71-96. (Pubitemid 351521864)
2. Gustafsson B, Iabc, Kidd Ma, Modlin IMa. Neuroendocrine tumors of the diffuse neuroendocrine system. Curr Opin Oncol. 2008;20: 1-12. (Pubitemid 350190975)
3. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972;64:413-421.
4. Engelbreth-Holm J. Benign bronchial adenomas. Acta Chir Scand. 1944-1945;90:383-409.
5. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529-553.
6. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22:934-944. (Pubitemid 28364493)
7. Seligson DB, Horvath S, Shi T, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005;435: 1262-1266. (Pubitemid 40943093)
8. Barlesi F, Giaccone G, Gallegos-Ruiz MI, et al. Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol. 2007;25:4358-4364. (Pubitemid 350013840)
9. Van Den Broeck A, Brambilla E, Moro-Sibilot D, et al. Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non-Small Cell Lung Cancer. Clin Cancer Res. 2008;14:7237-7245.
10. Fraga MF, Ballestar E, Villar-Garea A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37:391-400.
11. Travis WD, Brambilla E, Muller-Hermelink HK, et al. eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004.
12. Gomperts BN, Belperio JA, Fishbein MC, et al. Keratinocyte growth factor improves repair in the injured tracheal epithelium. Am J Respir Cell Mol Biol. 2007;37:48-56. (Pubitemid 46999536)
13. Xu H, Bourne PA, Spaulding BO, et al. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Hum Pathol. 2007;38:555-563. (Pubitemid 46399894)
14. Yi XP, Gerdes AM, Li F. Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats. Hypertension. 2002; 39:1058-1063. (Pubitemid 34620124)
15. Lachner M, O'Carroll D, Rea S, et al. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 2001;410: 116-120. (Pubitemid 32225847)
16. Mikkelsen TS, Ku M, Jaffe DB, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007;448:553-560. (Pubitemid 47206934)
17. Kourmouli N, Jeppesen P, Mahadevhaiah S, et al. Heterochromatin and tri-methylated lysine 20 of histone H4 in animals. J Cell Sci. 2004;117:2491-2501. (Pubitemid 38877845)
18. Schotta G, Lachner M, Sarma K, et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 2004;18:1251-1262. (Pubitemid 38720593)
19. Pogribny IP, Ross SA, Tryndyak VP, et al. Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis. 2006;27: 1180-1186. (Pubitemid 43985433)
20. Sarg B, Koutzamani E, Helliger W, et al. Postsynthetic Trimethylation of Histone H4 at Lysine 20 in Mammalian Tissues Is Associated with Aging. J Biol Chem. 2002;277:39195-39201. (Pubitemid 35190888)
21. Koch CM, Andrews RM, Flicek P, et al. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res. 2007;17:691-707. (Pubitemid 46919707)
22. Kurdistani SK, Tavazoie S, Grunstein M. Mapping Global Histone Acetylation Patterns to Gene Expression. Cell. 2004;117:721-733. (Pubitemid 38748889)
23. Akhtar A, Becker PB. Activation of transcription through histone H4 Acetylation by MOF, an acetyltransferase essential for dosage compensation in drosophila. Molecular Cell. 2000;5: 367-375. (Pubitemid 30628093)
24. Shogren-Knaak M, Ishii H, Sun JM, et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science. 2006;311:844-847. (Pubitemid 43228847)
25. Zhou Y, Grummt I. The PHD Finger/Bromodomain of NoRC Interacts with Acetylated Histone H4K16 and Is Sufficient for rDNA Silencing. Curr Biol. 2005;15:1434-1438. (Pubitemid 41097550)